Fig. 5From: Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancerMFS curves of IBC patients stratified by PIK3CA mutation. a Kaplan-Meier estimates of MFS according to PIK3CA mutations in total IBC patients (n = 114); b Kaplan-Meier estimates of MFS according to PIK3CA mutations in the TNBC subgroup (n = 38); c Kaplan-Meier estimates of MFS according to PIK3CA mutations in the HR–/HER2+ subgroup (n = 26); d Kaplan-Meier estimates of MFS according to PIK3CA mutations in the HR+/HER2– subgroup (n = 41). HR hazard ratioBack to article page